Lacriflow CL— 510(k) K170247

Name: FDA 510(k) clearance K170247
Creator: U.S. Food and Drug Administration
Published: 2017-04-18

Substantially Equivalent

Kaneka Pharma America, LLC

FDA 510(k) clearance K170247 for Lacriflow CL, Substantially Equivalent on 2017-04-18. Applicant: Kaneka Pharma America, LLC. Device class: Unclassified.

Clearance details

Applicant: Kaneka Pharma America, LLC
Product code: Code OKS
Device class: Unclassified
Advisory panel: Unknown
Date received: 2017-01-27
Decision date: 2017-04-18
Decision: Substantially Equivalent
Clearance type: Special
Location: New York, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code OKS

view all

K201892 — Ritleng®+ and Ritleng®+ PVP2021-03-11
K201606 — LacriJet®2020-12-18
K161373 — Nunchaku2016-11-03
K160710 — Oasis Lacrimal Intubation Set2016-05-13
K142914 — DacryoCATH2015-01-12

More clearances from Kaneka Pharma America, LLC

view all

K192068 — i-ED COIL2020-04-25
K121301 — XPRESSWAY RX CATHETER (6F LD-VERISON)2012-07-30
K101839 — KANEKA PHARMA AMERICA XPRESS-WAY RX2010-10-22

Data sourced from openFDA. This site is unofficial and independent of the FDA.